BSX NYSE
Boston Scientific Corporation
1W: +6.7%
1M: -11.9%
3M: -23.4%
YTD: -39.7%
1Y: -46.4%
3Y: +6.3%
5Y: +37.5%
$57.78
+0.63 (+1.10%)
Weekly Expected Move ±7.1%
$45
$49
$53
$56
$60
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$21B
Revenue
+17.4% YoY
$4B
Net Income
+74.8% YoY
$3B
Free Cash Flow
+19.8% YoY
69.4%
Gross Margin
20.6%
Op. Margin
25.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE15.4%
ROA8.6%
ROIC11.4%
Valuation
P/E24.0
P/B3.3
EV/EBITDA21.9
Leverage
Debt/Equity0.51
Current Ratio1.62
Interest Cov.11.4x
Quality Scores
Piotroski F8/9
Altman Z3.98
Beneish M-2.47